期刊文献+

上皮细胞钙粘蛋白与β-连环蛋白在恶性腹水鉴别诊断中的价值 被引量:3

An Evaluation of E-cadherin and β-catenin in differentiation of Malignant Ascites
下载PDF
导出
摘要 目的通过检测不同病因腹水中上皮细胞钙粘蛋白(E—cadherin)和β-连环蛋白(β-catenin)的含量,探讨其在鉴别良、恶性腹水性质中的意义。方法收集41例来自临床上已确诊患者的腹水标本,分为结核组(5例)、肝硬化组(11例)和恶性肿瘤组(25例)3组,采用酶联免疫吸附法(ELISA)检测E—cadherin和β—catenin的含量。结果结核性腹水E—cadherin水平为(7.57±0.48)ng/L,肝硬化腹水水平为(8.18±0.81)ng/L,恶性腹水水平为(9.35±1.84)ng/L。结核性腹水β-catenin水平为(0.76±0.13)ng/L,肝硬化腹水为(0.93±0.06)ng/L,恶性腹水为(1.67±1.16)ng/L。恶性腹水E—cadherin和β-catenin水平明显高于结核性腹水和肝硬化性腹水(P〈0.05),两者水平在结核性腹水和肝硬化腹水之间比较差异无显著性(P〉0.05)。相关分析表明E—cadherin和β—catenin的表达具有正相关性(P〈0.01,r=0.479)。结论E-cadherin和β-catenin与肿瘤的浸润和转移有关,恶性腹水中两者的水平显著增高。E—cadherin和β—catenin对良、恶性腹水鉴别诊断有重要价值。 Objective Analysis the levels of E-cadherin and β-catenin in neoplastic,hepatic cirrhotic and tuberculous ascitic fluid to determine the value of E-cadherin and β-catenin for differentiating [ min1 ]. Methods E-cadherin and β-catenin levels were detected in ascitic fluid from 5 patients with tuberculous disease, 11 patients with cirrhosis, and 25 patients with neoplasm by EL ISA methods. Results The level of E-cadherin was 7.57 ± 0.48 ng/ L in tuberculous group,8.18 ± 0. 81 ng/ L in cirrhosis group,and 9.35 ± 1.84 ng/L in neoplastic group. The level of β-catenin was 0.76±0.13 ng/L in tuberculous group,0.93 ±0.06 ng/ L in cirrhotic group,and 1.67 ± 1.16 ng/L in neoplastic ascites . E-cadherin and β-catenin in patients with neoplasm were much higher than those with tuberculous disease and cirrhosis(P 〈0. 05 ). No difference of those between hepatic cirrhosis and tuberculous peritonitis was found. There was positive correlation between the expression of E-cadherin and β-catenin ( P 〈 0. 01, r = 0.479). Conclusion E-cadherin and β-catenin expression is involved in the incursion and metastasis of the neoplasm,and the levers of them were significantly elevated in neoplastic group. So there would be some difference between malignancy-related and no-malignancy-related ascites. The detection of E-cadherin and β-catenin levels is useful in the differential diagnosis of benign and malignant ascites.
出处 《临床内科杂志》 CAS 2009年第5期315-317,共3页 Journal of Clinical Internal Medicine
关键词 恶性腹水 上皮细胞钙粘蛋白 Β-连环蛋白 Malignant Ascites E-cadherin β-catenin
  • 相关文献

参考文献15

  • 1Ordonez NG. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol,2003 ,34 :749-755.
  • 2Cong F, Zhang J, PaoW, etal. A protein knockdown strategy to study the function of beta-catenin in tumorgenesis. BMCMol Bio,2003,410-421.
  • 3MullerT, Bain G, WangX, et al. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res, 2002, 280 : 119-133.
  • 4Bukholm IK, Nesland JM, Karesen R, et al. E-cadherin and alpha-, beta-,gamma-eatenin proteins expression in relation to metastasis in human breast carcinoma. Pathol, 1998,185:262.
  • 5Lim SC, LeeMS. Significance of E-cadherin/beta-catenin complex and cyclinD1 in breast cancer. OncolRep,2002,9:915-928.
  • 6Meena Jaggi, Sonny L, Johansson, et al. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urologic Oncology, 2005,23:402-406.
  • 7Salon C, LantuejoulS, Evmin B, et al. The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis. Future Oncol,2005 ,1:649-660.
  • 8JamoraC, FuchsE. Intercellular adhesion, signaling and the cytosk eleton. NatCellBiol,2002,4 : 101-108.
  • 9Katayama M, Hirai S, Kamihagi K, et al. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer, 1994,64: 580-585.
  • 10JuhaszM, EbertMPA, Schulz HU, et al. Dual role of serum soluble E - cadherin as a biological marker of metastatic development in gastric cancer. Gastroenterol,2003 ,38 :850.

二级参考文献9

  • 1Stewart B W, Kleihues P. World Cancer Report[M]. Lyon: IARC Press for IARC/WHO, 2003: 203-207.
  • 2Mittari E, Charalabopoulos A, Batistatou A, et al. The role of E-cadherin/catenin complex in laryngeal cancer[J]. Exp Oncol, 2005,27(4) :257-261.
  • 3Koike H, Ichikawa D, Ikoma H, et. al. Comparison of methylation-specific olymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients[J]. J Surg Oncol, 2004, 87(4) : 182-186.
  • 4Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3 kinase/ AKT pathways[J]. Oncogene, 2005, 24(50):7443-7454.
  • 5Asayama Y, Taguchi K K, Aishima S S, et al. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cad- herin, alpha-catenin and beta-catenin[J]. Liver, 2002, 22 (1) : 43-50.
  • 6Qin L X, Tang Z Y. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature[J]. J Cancer Res Clin Oncol, 2004,130 (9) :497-513.
  • 7Auerkari E I. Methylation of tumor suppressor genes p16 (INK4a), p27(Kipl) and E-cadherin in carcinogenesis[J]. Oral Oncol, 2006,42(1) :5-13.
  • 8吴衡,沈敏雄,梁玉龙,段玲玲,王丽影,徐贞,查锡良.阳性表达表皮钙粘蛋白增加G0/G1期人乳腺癌细胞比例及其分子机制[J].生物化学与生物物理进展,2003,30(3):435-441. 被引量:10
  • 9陈孝平,裘法祖,吴在德.原发性肝癌要按个体化采用以手术为主的综合治疗[J].中华外科杂志,2003,4(3):161-162. 被引量:50

同被引文献40

  • 1栾英姿,李力,黎丹戎,张玮,唐步坚.五种卵巢癌耐药细胞系的建立及其部分耐药相关基因的表达[J].中华妇产科杂志,2004,39(6):403-407. 被引量:21
  • 2Wu M, Pastor-Pareja JC, Xu T. Interaction between Ras ( VI2)and scribbled clones induces tumour growth and invasion. Nature,2010,463(7280):545-548.
  • 3Jingting C, Yangde Z, Yi Z,et al. Heparanase expression corre-lates with metastatic capability in human choriocarcinoma. Gynecol0ncol,2007,107( l):22-29.
  • 4Chien AI, Moon RT. WNTS and WNT receptors as therapeutictools and targets in human disease processes. Front Biosci, 2007,12:448457.
  • 5Hamada S,Watanabe K, Hirota M, et al. beta~Catenin/TC?/LEF regulate expression of the short form human Cripto-1. Bio-chem Biophys Res Commun,2007,355(1) :240-244.
  • 6Bozaci EA,Ta^kin S,Giirkan 0,et al. Intracavitary cardiac me-tastasis and pulmonary tumor emboli of choriocarcinoma : the firstcase diagnosed and treated without surgical intervention. GynecolOncol,2005,99(3) :753-756.
  • 7Goldstein DP, Berkowitz RS. Current management of gestationaltrophoblastic neoplasia. Hematol Oncol Clin North Am,2012,26?1):111-131.
  • 8Pongracz JE, Stockley RA. Wnt signalling in lung developmentand diseases. Respir Res,2006,7 :15.
  • 9Vangipuram SD, Buck SA, Lyman WD. Wnt pathway activityconfers chemoresistance to cancer stem-like cells in a neuroblasto-ma cell line. Tumour Biol,2012,33(6) :2173-2183.
  • 10Xu N, Shen C,Luo Y, et al. Upregulated miR-130a increasesdrug resistance by regulating RUNX3 and Wnt signaling in cispla-tin-treated HCC cell. Biochem Biophys Res Commun ,2012,425(2):468472.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部